Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Netflix backs out of bid for Warner Bros. Discovery, giving studios, HBO, and CNN to Ellison-owned Paramount
In a one-two punch of centibillion-dollar offers, the bidding war for Warner Bros. Discovery is over. David Ellison-owned Paramount will acquire Warner Bros. Discovery. Netflix has lost.
Others
Meta-backed Hupo finds growth after pivot to AI sales coaching from mental wellness
Hupo, backed by Meta, pivoted from mental wellness to AI sales coaching for banks and insurers, and secured a $10M Series A led by DST Global
OpenAI buys tiny health records startup Torch for, reportedly, $100M
AI health records startup Torch will be using its tech for OpenAI’s new ChatGPT Health, according to co-founder Ilya Abyzov.
Hands-on with Bee, Amazon’s latest AI wearable
We tried Amazon’s new AI wearable Bee. It’s not for pro users yet, but more features are expected this year.
Why Amazon bought Bee, an AI wearable
Amazon explains where its wearable Bee fits in and whether it will merge with Alexa.
Mark Zuckerberg says Meta is launching its own AI infrastructure initiative
Meta is ramping up its efforts to build out its AI capacity.
Anthropic announces Claude for Healthcare following OpenAI’s ChatGPT Health reveal
Anthropic’s Claude for Healthcare is unveiled about a week after OpenAI announced its ChatGPT Health product.
Pebble founder says his new company is ‘not a startup’
Pebble’s founder talks about how his new company is doing things differently.
Anthropic’s new Cowork tool offers Claude Code without the code
Built into the Claude Desktop app, Cowork lets users designate a specific folder where Claude can read or modify files, with further instructions given through the standard chat interface.
Trump’s EPA plans to ignore health affects of air pollution
The Trump administration is planning to stop assigning value to human life when analyzing the costs and benefits of air pollution controls.